Georg Friedrich Händel was a musical giant and probably the first composer to be the manager and promoter of his own works. The story of his life and illnesses is full of myths, invented and embellished by various biographies. Existing pathographies written by authors from various specialities suggested he suffered from psychiatric diseases like cyclothymia or mania and rheumatologic disorders like arthritis, while others tended to interpret his recurrent palsies as typical sequelae of ischemic strokes. During the last years of life, Händel was struck with blindness, which in his era was interpreted as being due to cataracts. This led to three ‘coucher’ operations, all of them without lasting effect. Although a definite diagnosis cannot be inferred from the original sources, the most plausible explanation for Händel’s palsies and visual impairment may be cerebrovascular disease. The possible differential diagnosis will be discussed in this paper.

Keywords:
Georg Friedrich Händel, Historical article, Carotid stenosis, Stroke, Blindness
1.
Chrysander F: Georg Freidrich Händel. Leipzig, Breitkopf & Härtel 1858, 1860, 1867.
2.
Flesch S, Baselt B (eds): Händel-Handbuch. Dokumente zu Leben und Schaffen. Kassel, Bärenreiter, 1978–1986.
3.
Deutsch OE: Handel. A Documentary Biography. London, Black, 1955.
4.
Rackwitz W: Georg Friedrich Händel. Lebensbeschreibung in Bildern. Leipzig: VEB Deutscher Verlag für Musik, 1986.
5.
Coxe W: Anecdotes of G.F. Handel and J.C. Smith. London, 1799, pp 26–27.
6.
Mainwaring J: Memoirs of the Life of the Late George Frideric Handel. London, Dodsley, 1760.
7.
Keynes M: Handel’s illnesses. Lancet 1980;ii:1354–1355.
8.
Frosch WA: The ‘Case’ of George Frideric Handel. N Engl J Med 1989;321:765–769.
9.
Zweig S: Georg Friedrich Händel’s Auferstehung; in Sternstunden der Menschheit. Leipzig, Insel, 1929.
10.
Leichtentritt H: Händel. Stuttgart, Deutsche Verlags-Anstalt, 1924.
11.
Mann A: Eine unbekannte Notiz zur Händel-Biographie. Händeljahrbuch 1985;31:61–62.
12.
Szabo K, Kern R, Gass A, Hirsch J, Hennerici M: Acute stroke patterns in patients with internal carotid artery disease: A diffusion-weighted magnetic resonance imaging study. Stroke 2001;32:1323–1339.
13.
Hennerici M, Daffertshofer M: Patterns of motor dysfunction after stroke; in Fisher M, Bogousslavsky (eds): Current Review of Cerebrovascular Disease. Edinburgh, Churchill Livingstone, 1995, vol 2, pp 93–106.
14.
Gass A, Szabo K, Behrens S, Rossmanith C, Hennerici M: A diffusion-weighted MRI study of acute ischemic distal arm paresis. Neurology. 2001;57:1589–1594.
15.
Back T, Mrowka M: Infarction of the ‘hand knob’ area. Neurology 2001;57:1143.
16.
The Amaurosis fugax Study Group. Current management of amaurosis fugax. Stroke 1990;21:201–208.
17.
Goodwin JA, Gorelick PB, Helgason CM: Symptoms of amaurosis fugax in atherosclerotic carotid artery disease. Neurology 1987;37:829–832.
18.
Chawluk JB, Kushner MJ, Bank WJ, Silver FL, Jamieson DG, Bosley TM, Conway DJ, Cohen D, Savino PJ: Atherosclerotic carotid artery disease in patients with retinal ischemic syndromes. Neurology 1988;38:858–863.
19.
Bogousslavsky J, Regli F, Zografos L, Ugle A: Optico-cerebral syndrome: Simultaneous hemodynamic infarction of optic nerve and brain. Neurology 1987;37:263–268.
20.
Staaf G, Lindgren A, Norrving B: Pure motor stroke from presumed lacunar infarct: long-term prognosis for survival and risk of recurrent stroke. Stroke 2001;32:2592–2596.
21.
Fisher CM: A lacunar stroke. The dysarthria-clumsy hand syndrome. Neurology 1967;17:614–617.
22.
Franken FH: Die Krankheiten grosser Komponisten. Wilhelmshafen, Noetzel, 1997, vol 4.
© 2004 S. Karger AG, Basel
2004
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.